
Keywords: BRA, B-Raf proto-oncogene, serine/threonine kinase; CD, Cluster of Differentiation; CDKN2A, Cyclin-dependent kinase inhibitor 2A; CI, Confidence interval; CIMP, CpG island methylator phenotype; CRC, Colorectal cancer; HLA, Human leucocyte antigen; HPF, Hi